9206-018 
9206-019 
9206-020* 
9206-021 
9206-022* 
9206-023 
(T) Brenner, Malcolm K.; Furman, Wayne; Santana, Victor; Bowman, 
Laura; and Meyer, William, St. Jude Children's Research Hospital; 
Phase I Study of Cytokine-Gene Modified Autologous Neuroblastoma 
Cells for Treatment of Relapsed/Refractory Neuroblastoma. 
Date of RAC Approval: 6-1-92 
Date of NIH Approval: 8-14-92 
(T) Oldfield, Edward, National Institutes of Health; Gene Therapy for the 
Treatment of Brain Tumors Using Intra-Tumoral Transduction with the 
Thymidine Kinase Gene and Intravenous Ganciclovir. 
Date of RAC Approval: 6-1-92 
Date of NIH Approval: 8-14-92 
(M) Deisseroth, Albert B., MD Anderson Cancer Center; Use of Two 
Retroviral Markers to Test Relative Contribution of Marrow and 
Peripheral Blood Autologous Cells to Recovery After Preparative Therapy. 
Date of RAC Approval: 6-2-92 
Date of NIH Approval: 8-14-92 
Minor Modification: 4-19-93 
(T) Gansbacher, Bemd; Houghton, Alan; and Livingston, Philip, Memorial 
Sloan Kettering Cancer Center; Immunization with HLA-A2 matched 
Allogeneic Melanoma Cells that Secrete Interleukin-2 in Patients with 
Metastatic Melanoma. 
Date of RAC Approval: 6-2-92 
Date of NIH Approval: 8-14-92 
(T) Gansbacher, Bemd; Motzer, Robert; Houghton, Alan; and Bander, 
Neil, Memorial Sloan Kettering Cancer Center; Immunization with 
Interleukin-2 Secreting Allogeneic HLA-A2 Matched Renal Cell 
Carcinoma Cells in Patients with Advanced Renal Cell Carcinoma. 
Date of RAC Approval: 6-2-92 
Date of NIH Approval: 8-14-92 
Minor Modification: 3-31-93 
(M) Dunbar, Cynthia, National Institutes of Health; Retroviral-Mediated 
Gene Transfer of Bone Marrow and Peripheral Blood Stem Cells During 
Autologous Bone Marrow Transplantation for Multiple Myeloma. 
Date of RAC Approval: 6-2-92 
Date of NIH Approval: 8-14-92 
Recombinant DNA Research, Volume 18 
[231] 
